Chronic Kidney Disease
Part of NephTimes
Does the prevalence of cardiovascular-kidney-metabolic syndrome stages vary by social determinants of health? The FDA has approved Ozempic (semaglutide) to treat chronic kidney disease (CKD) in adults with type 2 diabetes. A study examined the clinical relevance of urinary mRNA levels in patients with IgA nephropathy (IgAN). A study examined the efficacy and safety of conversion from treatment with the long-acting ESA MPG-EPO to vadadustat. Researchers examined ULT and the risk of CKD progression among patients with impaired kidney function and gout. What is the association of gout with CV disease and mortality risk in patients with type 2 diabetes and can CKD modify it? A secondary analysis of DCP trial data sought to understand the effects of thiazide diuretics on kidney outcomes. Researchers studied the association between chronic kidney disease and postoperative complications. Researchers studied the association of obesity severity and duration with chronic kidney disease incidence. The FDA rejected Zynquista as an add-on to insulin therapy for adults with type 1 diabetes and CKD. A global review noted changes in kidney care delivery but revealed gaps in access to kidney replacement therapies. A study examined the association of APOL1 risk variants and genotypes with chronic kidney disease among West Africans. The European label for Ozempic will be updated to include risk reduction for events related to kidney disease. The NCQA awarded Interwell Health a Population Health Program Accreditation for its Interwell 360 program for those with CKD. Vlado Perkovic spoke about findings from the FLOW, APPLAUSE-IgAN, and CREDENCE trials presented at ASN Kidney Week. Researchers studied the associations between the timing of a patient’s first cigarette and the risk of CKD. A study tested whether a urine acid/base score using both using urinary pH and NH4+could better predict CKD progression. A study examined an association between hyperglycemic crises at diabetes diagnosis and a higher risk of developing CKD. A study assessed the relationship between CKD and osteoarthritis, which share several similar risk factors. Researchers compared incidence of mortality and kidney failure between patients with CKD and rare kidney diseases.